For instance, genetically predicted lower LV expression of TMEM182 (encoding a regulator of myoblast differentiation34) and lower genetically predicted blood expression of FBXO32 (a recessive DCM gene35,36) were associated with increased DCM risk. The gene discussed is FBXO32; the disease is familial dilated cardiomyopathy.